Literature DB >> 24457811

Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol.

Francesc Figueras1, Eduard Gratacós.   

Abstract

Small fetuses are defined as those with an ultrasound estimated weight below a threshold, most commonly the 10th centile. The first clinically relevant step is the distinction of 'true' fetal growth restriction (FGR), associated with signs of abnormal fetoplacental function and poorer perinatal outcome, from constitutional small-for-gestational age, with a near-normal perinatal outcome. Nowadays such a distinction should not be based solely on umbilical artery Doppler, since this index detects only early-onset severe forms. FGR should be diagnosed in the presence of any of the factors associated with a poorer perinatal outcome, including Doppler cerebroplacental ratio, uterine artery Doppler, a growth centile below the 3rd centile, and, possibly in the near future, maternal angiogenic factors. Once the diagnosis is established, differentiating into early- and late-onset FGR is useful mainly for research purposes, because it distinguishes two clear phenotypes with differences in severity, association with preeclampsia, and the natural history of fetal deterioration. As a second clinically relevant step, management of FGR and the decision to deliver aims at an optimal balance between minimizing fetal injury or death versus the risks of iatrogenic preterm delivery. We propose a protocol that integrates current evidence to classify stages of fetal deterioration and establishes follow-up intervals and optimal delivery timings, which may facilitate decisions and reduce practice variability in this complex clinical condition.

Entities:  

Mesh:

Year:  2014        PMID: 24457811     DOI: 10.1159/000357592

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  105 in total

1.  Mediterranean diet, Mindfulness-Based Stress Reduction and usual care during pregnancy for reducing fetal growth restriction and adverse perinatal outcomes: IMPACT BCN (Improving Mothers for a better PrenAtal Care Trial BarCeloNa): a study protocol for a randomized controlled trial.

Authors:  Francesca Crovetto; Fàtima Crispi; Roger Borras; Cristina Paules; Rosa Casas; Andrés Martín-Asuero; Angela Arranz; Eduard Vieta; Ramon Estruch; Eduard Gratacós
Journal:  Trials       Date:  2021-05-24       Impact factor: 2.279

2.  Influence of breastfeeding and postnatal nutrition on cardiovascular remodeling induced by fetal growth restriction.

Authors:  Merida Rodriguez-Lopez; Lyda Osorio; Ruthy Acosta-Rojas; Josep Figueras; Monica Cruz-Lemini; Francesc Figueras; Bart Bijnens; Eduard Gratacós; Fatima Crispi
Journal:  Pediatr Res       Date:  2015-09-15       Impact factor: 3.756

3.  Intermediate Diastolic Velocity as a Parameter of Cardiac Dysfunction in Growth-Restricted Fetuses.

Authors:  Xiangna Tang; Edgar Hernandez-Andrade; Hyunyoung Ahn; Maynor Garcia; Homam Saker; Steven J Korzeniewski; Adi L Tarca; Lami Yeo; Sonia S Hassan; Roberto Romero
Journal:  Fetal Diagn Ther       Date:  2015-08-12       Impact factor: 2.587

4.  Disrupted placental serotonin synthetic pathway and increased placental serotonin: Potential implications in the pathogenesis of human fetal growth restriction.

Authors:  Suveena Ranzil; Stacey Ellery; David W Walker; Cathy Vaillancourt; Nadia Alfaidy; Alexander Bonnin; Anthony Borg; Euan M Wallace; Peter R Ebeling; Jan Jaap Erwich; Padma Murthi
Journal:  Placenta       Date:  2019-05-23       Impact factor: 3.481

5.  Can Fetal Growth Velocity and First Trimester Maternal Biomarkers Improve the Prediction of Small-for-Gestational Age and Adverse Neonatal Outcome?

Authors:  Manouk L E Hendrix; Judith A P Bons; Roy R G Snellings; Otto Bekers; Sander M J van Kuijk; Marc E A Spaanderman; Salwan Al-Nasiry
Journal:  Fetal Diagn Ther       Date:  2019-05-08       Impact factor: 2.587

Review 6.  Fetal programming as a predictor of adult health or disease: the need to reevaluate fetal heart function.

Authors:  Joana O Miranda; Carla Ramalho; Tiago Henriques-Coelho; José Carlos Areias
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

7.  Neural injury markers in intrauterine growth restriction and their relation to perinatal outcomes.

Authors:  E Mazarico; E Llurba; R Cumplido; A Valls; J C Melchor; M Iglesias; L Cabero; E Gratacós; M D Gómez-Roig
Journal:  Pediatr Res       Date:  2017-05-31       Impact factor: 3.756

8.  Maternal low molecular weight heparin versus sildenafil citrate for fetal growth restriction: a randomized, parallel groups, open-label clinical trial.

Authors:  R Rasheedy; G El Bishry; R Tarek
Journal:  J Perinatol       Date:  2019-11-06       Impact factor: 2.521

Review 9.  Clinician performed ultrasound in fetal growth restriction: fetal, neonatal and pediatric aspects.

Authors:  A Sehgal; F Crispi; M R Skilton; W-P de Boode
Journal:  J Perinatol       Date:  2017-08-24       Impact factor: 2.521

10.  Experimentally induced intrauterine growth restriction in rabbits leads to differential remodelling of left versus right ventricular myocardial microstructure.

Authors:  Julia Schipke; Anna Gonzalez-Tendero; Lidia Cornejo; Alper Willführ; Bart Bijnens; Fatima Crispi; Christian Mühlfeld; Eduard Gratacós
Journal:  Histochem Cell Biol       Date:  2017-07-10       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.